JPRN-UMIN000008730已完成未知
Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA) - AQUALA study
Graduate School of Medicine, The University of Tokyo0 个研究点目标入组 760 人开始时间: 2012年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 760
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who are not indicated for a primary THA 2) Patients with unstable clinical conditions 3) Patients whose weight is over the weight restriction of the femoral components to be used 4) Patients who are difficult to be followed for 5 years after the index surgery 5) Patients who are unable to evaluate their own QOL 6) Patients whose functions of the hip joints are difficult to evaluate due to disorders of other organs such as heart and nervous system 7) Patients who once had an artificial hip joint in the same hip joint 8) Patients who are at high risk of thrombosis or bleeding 9) Patients susceptive to infection 10)Patients receiving the anticancer drug therapy 11)Patients who are evaluated to be unsuitable for the subject of this study by the investigators
研究者
相似试验
已完成
不适用
Multicenter clinical study to assess the effectiveness and safety of Trident II in total hip arthroplasty (THA)Osteoarthritis, Femoral head necrosis, Rheumatoid arthritis, fractureJPRN-UMIN000043715Stryker Japan K.K.191
尚未招募
不适用
Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive ImpairmentMental and behavioural disordersKCT0007184Inha University Hospital100
尚未招募
不适用
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
招募中
2 期
Multicenter clinical trial to evaluate the efficacy of rituximab combination chemotherapy for children or AYAswith localized mature B-cell lymphomaJPRN-jRCTs041210104Sekimizu Masahiro100
进行中（未招募）
1 期
Multicentre clinical trial to evaluate the efficacy and safety of dexketoprofen trometamol (50 mg t.i.d.) versus ketorolac (30 mg t.i.d.) and placebo by intravenous route, as part of balanced analgesic therapy with morphine, followed by an oral dosing, in the treatment of postoperative paielective orthopedic surgery (hip arthroplasty)MedDRA version: 7.0Level: PTClassification code 10020096EUCTR2004-001373-26-ESaboratorios Menarini, S.A